UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $268,000 | -22.3% | 12,924 | +19.8% | 0.51% | +11.1% |
Q3 2021 | $345,000 | +3.9% | 10,787 | +9.4% | 0.46% | +41.1% |
Q1 2021 | $332,000 | +37.2% | 9,857 | +47.1% | 0.33% | +26.4% |
Q4 2020 | $242,000 | -43.3% | 6,700 | -42.2% | 0.26% | +15.7% |
Q3 2020 | $427,000 | +39.1% | 11,600 | +70.1% | 0.22% | +8.8% |
Q2 2020 | $307,000 | -3.2% | 6,821 | +1.9% | 0.20% | -14.2% |
Q1 2020 | $317,000 | -26.3% | 6,691 | +11.4% | 0.24% | +0.4% |
Q4 2019 | $430,000 | -28.2% | 6,007 | -21.7% | 0.24% | -42.0% |
Q2 2019 | $599,000 | – | 7,670 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |